Wound infection secondary to snakebite by Wagener, M et al.
315       April 2017, Vol. 107, No. 4
RESEARCH
Snakebites can produce severe local and systemic septic complications 
in addition to the expected morbidity and even mortality caused 
by venom alone. In the majority of snakebite victims presenting 
to hospital, envenomation involves painful progressive swelling as 
the predominant symptom.[1,2] Other envenomation syndromes, 
including acute life-threatening coagulopathy, muscle weakness and 
respiratory paralysis, are rare.[1-4] Cases of severe envenomation are 
often characterised by subsequent wound infection and skin and soft-
tissue necrosis.[1,2]
While the role of antivenom administration in the treatment of 
acute envenomation has been well described,[4] treatment of the 
complex wounds that result from subsequent necrosis and infection 
needs further investigation. In a 1999 study by Blaylock[5] at Eshowe 
District Hospital, KwaZulu-Natal (KZN) Province, South Africa (SA), 
the bacterial aetiology of wound infection secondary to snakebite was 
described. Gram-negative aerobic Enterobacteriaceae were the most 
commonly isolated organisms in that study, but antibiotic susceptibility 
was not reported. In areas of high snakebite prevalence outside SA, a 
similar spectrum of bacterial species has been found and antibiotic 
sensitivities reported.[6-9] The bacterial cause of infected snakebite 
wounds in northern KZN has been determined by previous work, but 
antibiotic susceptibility remains untested. A current description of 
associated morbidity is also required.
Treatment of complex wounds resulting from cytotoxic snake 
envenomation poses multiple challenges. A multidisciplinary approach 
is required. Current treatment strategies need to be examined in order 
to reduce morbidity.
Numerous authors have recognised that the public health impact of 
snakebite has been underestimated.[9-12] Importantly, since the type of 
snake responsible for the majority of severe envenomation will vary 
between regions, the clinical problems associated with snakebite will 
also be unique for each region. The main envenomation syndrome 
in KZN is cytotoxicity.[1,2] It is postulated that the tissue destruction, 
disfigurement, amputation and physical disability that result from 
predominantly cytotoxic snake envenomation are responsible for the 
majority of the untold burden of disease in our region.[13,14] Indices to 
quantify this morbidity include length of hospital stay and objective 
assessment of resulting physical disability.[15]
The snakes that cause the greatest human suffering are those that bite 
frequently and have bites resulting in severe envenomation. [9,14] Snakes 
that bite frequently are those with behaviour associated with a high 
incidence of human contact. Snake species with these characteristics 
vary between regions.[9] The types of snake responsible for the majority 
of morbidity in our study population were examined.
Rural populations are at the greatest risk of snakebite.[10-12] Of 
particular concern is that in rural communities, the majority of 
snakebite victims are children.[1-4] The reasons for this phenomenon 
need to be examined. Novel strategies used to prevent bites may be 
possible, thus reducing long-term social and economic consequences.
Objective
A prospective audit was undertaken to determine the bacterial 
causation of wound infection secondary to snakebite in KZN, as well 
as attempt to quantify the burden of disease.
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Background. Snakebites can produce severe local and systemic septic complications as well as being associated with significant overall 
morbidity and even mortality.
Objective. A prospective audit was undertaken to determine the bacterial causation of wound infection secondary to snakebite, and attempt 
to quantify the burden of disease.
Methods. The audit was undertaken at Ngwelezane Hospital, which provides both regional and tertiary services for north-eastern KwaZulu-
Natal Province, South Africa, over a 4-month period. Records of patients who required surgical debridement for extensive skin and soft-
tissue necrosis were analysed. At the time of debridement, tissue samples of necrotic or infected tissue were sent for bacteriological analysis 
as standard of care. Microbiology results were analysed.
Results. A total of 164 patients were admitted to hospital for management of snakebite, of whom 57 required surgical debridement and 42 
were included in the final microbiological analysis. Children were found to be the most frequent victims of snakebite; 57.8% of patients in 
this study were aged ≤10 years and 73.7% ≤15 years. Culture showed a single organism in 32/42 cases, two organisms in 8 and no growth 
in 2. Eight different types of organisms were cultured, five of them more than once. Thirty-five specimens (83.3%) grew Gram-negative 
Enterobacteriaceae, the most frequent being Morganella morganii and Proteus species. Thirteen specimens (31.0%) grew Enterococcus 
faecalis. Gram-negative Enterobacteriaceae showed 31.4% sensitivity to ampicillin, 40.0% sensitivity to amoxicillin plus clavulanic acid, 
34.3% sensitivity to cefuroxime, 97.1% sensitivity to ceftriaxone, and 100% sensitivity to ciprofloxacin, gentamicin and amikacin. E. faecalis 
was 92.3% sensitive to amoxicillin, 92.3% sensitive to amoxicillin plus clavulanic acid, 100% sensitive to ciprofloxacin, 92.3% resistant to 
erythromycin and 100% resistant to ceftriaxone.
Conclusion. Children are particularly vulnerable to snakebite, and the consequences can be devastating. While the majority of patients in 
this study were shown to have secondary bacterial infection, debridement and subsequent wound management is considered the mainstay 
of treatment. Common organisms are Enterobacteriaceae and enterococci. There appears to be a role for antibiotics in the management of 
these patients. A good antibiotic policy is strongly advocated.
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Methods
The study was conducted at Ngwelezane 
Tertiary Hospital, situated in a semi-rural 
settlement outside the town of Empangeni, 
KZN, and serving a predominantly rural 
population. It is the referral centre for 
22 peri pheral hospitals and sees an alarming 
number of snakebites each year,[1,2] mainly in 
the summer months.[1-4]
During the 4-month period December 
2014 - March 2015, patients requiring surgi-
cal debridement of snakebite were enrolled 
prospectively. No new protocols were put in 
place for the purpose of the study, and study 
information represented standard patient 
management. A sample of necrotic tissue 
was taken from each patient and sent for 
bacteriological analysis. Pathogens isolated 
and antibiotic susceptibilities were recorded. 
In vitro culture of debrided tissue was done 
using blood agar and MacConkey agar 
culture media, and susceptibility testing was 
performed using the disc-diffusion method 
as per standard National Health Laboratory 
Service protocols.
Other data obtained to determine 
morbi dity included anatomical location of 
debridement, extent of debridement, need 
for re-debridement, method of wound clo-
sure, skin graft take, length of hospital stay 
and objective functional impairment. Each 
patient, or the caregiver if the victim was a 
child, was questioned on the type of snake 
they had been bitten by. Age and sex of vic-
tims were recorded.
Patients were included in the analysis 
of overall treatment but excluded from 
microbiological analysis if the wound had 
broken down spontaneously or had been 
informally debrided elsewhere, specimens 
had been lost or incorrectly processed, or the 
debridement had been done for skin necrosis 
only without any evidence of infection.
Data from each patient were recorded on 
an individual data collection pro forma. Data 
were then inserted into an Excel spreadsheet, 
version 15.27 (Microsoft, USA), for analysis.
Ethics approval was obtained from the 
Biomedical Research Ethics Committee of 
the University of Kwa-Zulu Natal. (ref. no. 
BE006/15).
Results
Description of the sample
A total of 164 patients were admitted 
with snakebite wounds during the study 
period, 57 (34.8%) of whom required surgi-
cal debridement. Fifteen patients were 
not included in the final microbiological 
analysis for the following reasons: (i) the 
wound had broken down spontaneously 
or been informally debrided elsewhere 
(n=5 patients); (ii) tissue specimens had 
been lost (n=6); (iii) tissue specimens had 
been incorrectly processed (n=2); and 
(iv) debridement had been done for skin 
necrosis without any evidence of infection, 
and microbiological analysis confirmed no 
bacterial growth (n=2).
Thirty-three patients (57.9%) were 
referred from rural district hospitals, either 
acutely (n=19, 57.6%) or as non-urgent 
cases referred to the department of surgery 
with wound complications after spending 
time at a peripheral hospital (n=14, 42.4%). 
Those with delayed referral spent a mean 
of 8.85 days (range 3 - 20) at the peripheral 
hospital prior to referral.
In 28 cases (49.1%), patients or their 
caregivers claimed to have identified the 
snake with confidence. Of the 28 posi-
tively identified snakes, 26 (92.9%) were 
Mozambique spitting cobras (Naja mossam-
bica), or ‘M’fezi’.
The most frequent victims of snakebite 
were found to be children, particularly those 
aged ≤10  years. Most of the victims in this 
study were aged ≤10 years (57.8%), and 
73.7% were aged ≤15 years (Fig. 1).
The majority of the bites occurred at 
night, 33/55 (60.0%) between 22h00 and 
08h00 and 17/55 (30.8%) in the evening 
between 18h00 and 22h00. Five bites (9.1%) 
occurred in the daylight hours of 08h00 - 
18h00. Most of the victims (86.0%) were 
bitten while sleeping.
Microbiological analysis
Of the 42 cases included in the final micro-
biological analysis, 76.2% (n=32) showed 
single growth, 19.0% (n=8) grew two organ-
isms, and in two cases (4.8%) there was no 
growth. Eight different types of organisms 
were cultured, five of them more than once.
Fig. 2 shows the various bacteria cultured. 
Thirty-five specimens (83.3%) grew Gram-
negative Enterobacteriaceae. Enterococcus 
faecalis was found in 13 specimens (31.0%). 
The two most frequent Gram-negative 
Enterobacteriaceae were Morganella morg-
Sn
ak
eb
ite
 v
ic
tim
s, 
n
18
16
14
12
10
8
6
4
2
0
Age (years)
0 -
 5
  6 
- 1
0
11
 - 1
5
16
 - 2
0
 21
 - 2
5
     
  26
 - 3
0
  31
 - 3
5
  36
 - 4
0
  41
 - 4
5
  46
 - 5
0
 50
 - 5
5
   5
6 -
 60
  61
 - 6
5
  66
 - 7
0
71
 - 7
5
29.8%
28.1%
    15.7%
  7.0%
  3.5%
1.7%    1.7%
  3.5%
  1.7% 1.7%
  3.5%
    1.7%
Morganella morganii
Enterococcus faecalis
Proteus species 
Salmonella enterica
Enterobacter cloacae complex 
Escherichia coli
Klebsiella pneumoniae
Citrobacter freundii
Ba
ct
er
ia
0         2          4          6          8        10       12       14       16        18
Frequency of culture, n
 
40.5%
31.0%
23.8%
7.1%
4.8%
2.4%
2.4%
2.4%
30
25
20
15
10
5
0
    N
on
e
     
     
    
          25
Fr
eq
ue
nc
y 
pr
es
cr
ib
ed
, n
Antibiotic
Am
oxi
cill
in p
lus
 
cla
vul
an
ic a
cid Clo
xac
illin
 Me
tro
nid
azo
le
     
Am
oxi
cill
in
  Ce
ftri
axo
ne
Ge
nta
mi
cin
23
6
 3 2  1 1
Fig. 1. Age distribution of patients.
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Fig. 2. Organisms grown from infected snakebite wounds.
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anii, which occurred in 40.5% of specimens, 
followed by Proteus species, which occurred 
in 23.8%. No anaerobes were found.
Antibiotic resistance
Gram-negative Enterobacteriaceae showed 
68.6% resistance to ampicillin, 60.0% resis-
tance to amoxicillin plus clavulanic acid, 
and 65.7% resistance to second-generation 
cephalo sporins. These organisms were 97.1% 
sensitive to ceftriaxone and 100% sensitive to 
ciprofloxacin and aminoglyosides. E. faec alis 
showed 92.3% sensitivity to both ampicillin 
and amoxicillin plus clavu lanic acid, as well as 
100% sensitivity to ciprofloxacin. Enterococci 
were 92% resis tant to erythromycin and 
100% resistant to cephalo sporins.
Thirty-two patients (56.1%) received 
empirical antibiotic therapy, either at pre-
sentation or shortly before debridement. 
Amoxicillin plus clavulanic acid was the 
most commonly used antibiotic. Cloxacillin, 
metronidazole, amoxicillin, ceftriaxone and 
gentamicin were also used (Fig. 3).
Morbidity and treatment outcomes
Of the 57 patients, 32 (56.1%) sustained 
upper limb bites, 20 (35.1%) lower limb 
bites, 5 (8.8%) bites to the torso and 2 (3.5%) 
facial bites, while 1 patient (1.8%) was bitten 
on the occiput of the head. Four patients 
(7.0%) sustained multiple bites.
The average delay from injury to surgi cal 
debridement was 7.8 days (range  3 - 22). 
Among patients presenting to the hospital 
within 48 hours of the bite, the delay in 
debridement was 5.2 days from admission. 
Sixteen patients (28.1%) required re-debri-
dement. In 27 cases (47.4%) a skin graft was 
necessary, in 26 cases (45.6%) wounds were 
small enough to heal by secondary intention, 
and in 4 cases this information was not 
recorded. Skin graft take was 80 - 100% 
in 20/27 patients (74.1%), and only one 
patient had complete skin graft failure. One 
patient in this cohort required fasciotomy. 
Four patients required digital amputations, 
but there were no major limb amputations. 
Two patients had severe and life-threatening 
sepsis as a result of wound infection.
The average length of hospital stay was 
31.3 days (range 3 - 74). Seven patients 
were assessed as having objective functional 
impairment in the form of digital amputa-
tion (n=4), difficulty in walking (n=2) and 
impaired elbow flexion (n=1).
Discussion
The majority of patients in this study 
were shown to have secondary bacterial 
infection. The clinical significance of these 
infections was variable. Clinically significant 
wound infection was considered to be 
present in all patients included in the final 
microbiologi cal analysis. These infections 
may affect wound healing, skin graft take 
and possibly even long-term morbidity. 
While debridement and subsequent wound 
management is considered the mainstay of 
treatment, antibiotic therapy is considered 
to be an important adjunct in these cases. 
Presence of a systemic inflammatory res-
ponse as a result of wound infection was not 
included in the data collection. Two patients 
had severe and life-threatening sepsis as a 
result of wound infection.
Gram-negative Enterobacteriaceae and 
E. faecalis were the most commonly iso-
lated organisms. Gram-negative Entero-
bacteriaceae showed high resistance to 
ampi cillin (68.6%), amoxicillin plus clavu-
lanic acid (60.0%), and second-generation 
cephalosporins (65.7%). Sensi tivity was 
adequate to ceftriaxone (97.1%) and cipro-
floxacin, gentamicin and amikacin (all 
100%). E. faecalis showed good sensitivity to 
ampicillin (92.3%), amoxicillin plus clavu-
lanic acid (92.3%) and ciprofloxa cin (100%).
We believe that cultured organisms repre-
sent true infection rather than conta minants, 
because the organisms grown are similar to 
those found in mouths of KZN snakes[16] 
and because wounds that had either broken 
down or been informally debrided elsewhere 
were excluded from the microbiological 
analysis.
Current recommendations advise against 
the prophylactic use of antibiotics in snake-
bites.[4,17] These recommendations are based 
on research showing a paucity of bacteria 
in snakes’ mouths and that venom has 
antibacterial properties.[16,18] There does, 
however, appear to be a role for antibiotics 
in the managenent of severe local and syste-
mic septic complications from snakebite, 
and we conclude that antibiotics play an 
important role in therapy of infected sna-
kebite wounds.
This study demonstrated that use of 
antibiotics in the management of snakebites 
was widespread and not directed. Amoxi-
cillin plus clavulanic acid was the most 
commonly used antibiotic, to which Gram-
negative bacteria from wounds cultured 
in this series showed 60.0% resistance. 
Cloxacillin was the next most commonly 
used antibiotic, and would have been of 
no benefit because staphylococcal infection 
has not been shown to occur in these 
patients. In cases where empirical therapy 
is deemed necessary, antibiotics need to 
cover Gram-negative Enterobacteriaceae 
and E. faecalis. According to these data, 
Gram-negatives would be covered by cipro-
floxacin, an aminoglycoside or a third-
generation cephalosporin. E. faecalis would 
be adequately covered by ampicillin or 
ciprofloxacin. A good antibiotic policy is 
strongly advocated.
Snakebite wounds are particularly unfor-
giving wounds to treat. There is often 
exposure of non-granulating surfaces and 
superimposed infection. In addition, vic-
tims are frequently young children who 
comply poorly with rehabilitation and pose 
challenges for dressing changes (Fig. 4). 
Upper limb and torso injuries pose parti-
cular difficulties. Nevertheless, by applying 
standard wound care principles, involving 
rehabilitation professionals early on and 
using a combination of delayed primary 
closure and skin grafting, it is possible to 
achieve a satisfactory result.
This study demonstrates the significant 
burden of disease caused by cytotoxic 
snake bite. This can be quantified firstly by 
length of hospital stay, (average 31.3 days). 
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Fig. 3. Antibiotic use.
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Additionally, patients in this study showed objective functional 
impairment in terms of digital amputation (n=4 cases), difficulty 
in walking (n=2) and impaired upper limb mobility (n=1). Of 
concern is that many patients, especially children, suffer permanent 
functional impairment that could not be adequately quantified by 
methods used in this study. Children with devastating extremity 
injuries are likely to have difficulty learning basic life skills, playing 
and performing at school.
With focused care and more aggressive treatment and rehabilitation, 
we believe that the average length of hospital stay can be reduced. 
When patient care is evaluated using the results of this study, this will 
be an area to focus on.
Victims’ identification of the offending snake has been described 
as unreliable in the literature,[2,4] but in this study 49.1% of patients 
or their caregivers confidently identified the snake, the majority 
being identified as M’fezi. Our opinion is that the majority of these 
reports are accurate. Most bites ascribed to the M’fezi occurred at 
night while sleeping, which is in keeping with the behaviour of this 
snake.[9,19,20] Secondly, many wounds showed characteristic features 
of M’fezi bites: necrosis involving skin and subcutaneous soft tissue, 
with patches of skin necrosis separated by normal-looking skin 
producing characteristic ‘skip lesions’ (Fig. 5)[9,19,21] or with extensive 
undermining of tissues (Fig. 6). Lastly, the snake is justifiably feared 
by the local population and is therefore well known.
This study demonstrates that rural populations are most at risk 
of snakebite: 57.9% of victims were referred from outlying rural 
hospitals. The likelihood of humans coming into contact with snakes 
is considerably increased in rural areas. Rural-dwelling families are 
at risk in their homes, and farmers and herders are at risk in their 
occupation.
Confirming what has been found in previous audits, children 
are particularly vulnerable to snakebite.[1-4] This has traditionally 
been thought to be a consequence of children’s naturally inquisitive 
behaviour,[2,4] but since the majority of patients in this study were 
bitten at night while sleeping, another explanation is needed. It 
is possible that these bites occur because children in our rural 
communities often sleep on the floor, while more senior members 
of the household occupy a bed. In addition to children being 
particularly vulnerable to snakebite, local and systemic envenomation 
syndromes occur more frequently and with greater severity in this 
age group.[4] This is probably due to the higher venom-to-mass ratio, 
as suggested by Blaylock.[1,16]
The numbers in this study were higher than those collected by 
Wood et al.[4] in their series from the same hospital in 2007/2008. 
That study recorded the highest number of snakebites in the 
months December - March, these being the only months during 
which data were collected in our study. During the same time 
frame, Wood et  al. had 132 patients, compared with 164 in our 
study. The reason for the discrepancy is likely to be twofold. Firstly, 
in 2007/2008 Wood et al. examined only patients presenting to the 
emergency department of Ngwelezane Hospital, while a number of 
patients in our study were referred to the department of surgery as 
non-urgent cases with wound complications after spending time at 
a peripheral hospital. Secondly, since 2012 referral patterns have 
changed, resulting in a greater number of district hospitals referring 
to Ngwelezane. There are no previous studies from Ngwelezane 
examining the number of snakebite victims requiring surgical 
debridement.
A delay of 5 - 7 days before debridement of necrotic snakebite 
wounds is recommended to allow demarcation of dead tissue. [16,22] 
In this study, this recommended time frame was achieved in 
patients presenting acutely to our hospital, with an average of 
5.2 days to debridement. However, patients referred from elsewhere 
experienced a longer delay to debridement owing to time spent 
at a peripheral hospital and time required for treatment with 
antibiotics after arriving at our hospital (Fig. 7), accounting for the 
longer overall delay to debridement for patients in this study. Two 
patients in our study experienced cardiorespiratory collapse as a 
complication of grossly infected wounds (Fig. 8), and in these cases 
we performed the debridement as an emergency in order to achieve 
source control in the treatment of severe sepsis.
The role of antivenom in preventing these devastating local 
and regional complications of snakebite is largely unknown. In 
a randomised, double-blind, placebo-controlled trial, antivenom 
was shown to accelerate oedema resolution in bites from green pit 
vipers in Thailand.[23] Antivenom has also been demonstrated to 
decrease compartment pressure with rattlesnake envenomation in 
an animal model from the USA.[24] However, these effects remain 
untested in Africa. The efficacy of antivenom in reducing skin and 
Fig. 4. Exposure of tendons in a necrotic septic snakebite wound after 
debridement. Fig. 5. Characteristic ‘skip lesions’ of M’fezi bite.
Fig. 6. Necrotic snakebite wound presumed to be from M’fezi bite.
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soft-tissue necrosis is also unknown. In a retrospective study from 
Thailand, antivenom was found to have no effect on the development 
of dermatonecrosis after green pit viper envenomation. [25] Current 
guidelines maintain that there is a role for antivenom administration 
for predominantly cytotoxic snakebite.[16,21] Owing to the significant 
potential risks of antivenom administration,[4,16] a risk/benefit evalu-
ation needs to be employed in each individual case.[26]
We maintain that the most important aspect of managing these 
patients after the acute phase is good initial debridement and robust 
postoperative care.
Study limitations
This analysis was confined to snakebites with the most severe necrosis 
requiring formal debridement in theatre. Anaerobic culture was not 
performed, as methods of specimen collection and culture require 
protection from oxygen for anaerobic organism identification. This 
procedure is not routine and was not implemented for the purpose 
of the study. Quantitative bacterial cultures were not performed. 
Incomplete data from lost or inappropriately processed specimens 
may have compromised results.
Conclusions and recommendations
We recommend that antibiotics should be used in selected cases, 
treatment being commenced only when the results of sensitivity 
tests are known. In cases of severe sepsis where empirical antibiotic 
therapy is needed, use of ciprofloxacin is recommended in adults 
and children, as this covers Gram-negative Enterobacteriaceae and 
E. faecalis, avoids the need for combination therapy, and is consid-
ered safe in children.[27,28] It is recommended that debridement be 
delayed until necrosis demarcates, usually after 5 - 7 days. Rare cases 
where the patient becomes systemically toxic should be treated with 
emergency debridement.
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Fig. 7. Patient referred with septic snakebite wound after being managed 
expectantly at a peripheral hospital.
Fig. 8. Child with severe sepsis complicating snakebite to left shoulder.
